Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
66 studies found for:    Open Studies | Exclude Unknown | digestive disease | NIDDK
Show Display Options
Rank Status Study
21 Recruiting Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
Condition: Cystic Fibrosis
22 Recruiting Natural History of Noncirrhotic Portal Hypertension
Conditions: Cystic Fibrosis;   Immunologic Deficiency Syndrome;   Turner Syndrome;   Congenital Hepatic Fibrosis;   Idiopathic Non-Cirrhotic Portal Hypertension
23 Recruiting Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
Condition: Hepatitis D
Interventions: Drug: Lonafarnib;   Drug: Ritonavir;   Other: Placebo
24 Recruiting Observational Study of Persons With Hepatitis B Virus Infection in North America
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
25 Recruiting Phenotyping IBS: Perceptions and Modulations of Visceral Sensations
Conditions: Irritable Bowel Syndrome;   Ulcerative Colitis;   Inflammatory Bowel Disease
26 Recruiting Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Condition: Fatty Liver
Interventions: Drug: Vitamin E 200 IU/d;   Drug: Vitamin E 400 IU/d;   Drug: Vitamin E 800 IU/d;   Behavioral: Diet and Exercise
27 Recruiting Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial
Condition: Gastroesophageal Reflux Disease
Intervention: Other: Study
28 Recruiting Mucosal Impedance in Pediatric Population
Conditions: Gastroesophageal Reflux Disease (GERD);   Eosinophilic Esophagitis (EoE);   Functional Dyspepsia
Intervention: Procedure: Standard of Care esophagogastroduodenoscopy (EGD) with mucosal impedance testing
29 Recruiting Diagnosing and Treating Low Blood Sugar Levels
Conditions: Hypoglycemia;   Insulinoma
30 Recruiting Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816
Condition: Chronic Hepatitis C
Interventions: Drug: Sofosbuvir;   Drug: GS-5816
31 Recruiting Mechanisms Associated With Favorable Responses to Peginterferon-Alpha Add-on Therapy Following Long-term Nucleos(t)Ide Analogue Treatment in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: Peginterferon alfa-2a
32 Recruiting Seroprevalence of Hepatitis E in People With an Organ Transplant
Condition: Hepatitis E
33 Recruiting Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
34 Recruiting Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
Condition: Hepatitis B
Interventions: Drug: Tenofovir/ & Emtricitabine;   Drug: Tenofovir
35 Recruiting Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
Condition: Cirrhosis
36 Recruiting Mechanisms and Management of Infant Dysphagia
Conditions: Dysphagia;   Airway Aspiration;   Airway Penetration
Interventions: Other: Slower Flow Rate;   Other: Thickened Formula
37 Recruiting Predicting Risk of Cancer in Barrett's Esophagus
Conditions: Barrett Esophagus;   Esophageal Neoplasm;   Gastroesophageal Reflux
38 Recruiting Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus
Condition: Eosinophilic Esophagitis
Intervention: Device: SECM Capsule
39 Recruiting Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Interventions: Drug: Oral Viscous Budesonide;   Drug: Fluticasone MDI;   Drug: Placebo slurry;   Drug: Placebo inhaler
40 Recruiting Microbiome Fructan Metabolism and Symptoms in Childhood IBS
Condition: Irritable Bowel Syndrome (IBS)
Interventions: Other: Fructan;   Other: Maltodextrin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years